hrp0098rfc10.3 | Multisystem Endocrine Disorders | ESPE2024
Bruzzi Patrizia
, Cattini Umberto
, Deonette Elisa
, Gargiulo Cano Carmen
, Palazzi Giovanni
, Iughetti Lorenzo
Background: Previous research demonstrated that survivors of childhood acute lymphoblastic leukemia (ALL), treated on the Italian Association of Pediatric Hematology and Oncology (AIEOP) protocols without radiotherapy between 1989 and 2000, generally achieve a normal final height with a body mass index (BMI) within the normal range. Nevertheless, their height catch-up growth is not fully restored after chemotherapy and BMI increases during treatment. In female...